Nektar Therapeutics's total assets for Q1 2025 were $256.24M, a decrease of -15.67% from the previous quarter. NKTR total liabilities were $242.50M for the fiscal quarter, a -0.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.